"The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of dalbavancin 500 mg (Xydalba, Durata Therapeutics) for acute bacterial skin and skin structure infections (ABSSSI) in ad"...
Metvixia Patient Information including If I Miss a Dose
In this Article
- What is methyl aminolevulinate (Metvixia)?
- What are the possible side effects of methyl aminolevulinate (Metvixia)?
- What is the most important information I should know about methyl aminolevulinate (Metvixia)?
- What should I discuss with my health care provider before taking methyl aminolevulinate (Metvixia)?
- How is methyl aminolevulinate used (Metvixia)?
- What happens if I miss a dose (Metvixia)?
- What happens if I overdose (Metvixia)?
- What should I avoid while taking methyl aminolevulinate (Metvixia)?
- What other drugs will affect methyl aminolevulinate (Metvixia)?
- Where can I get more information?
What happens if I miss a dose (Metvixia)?
Since methyl aminolevulinate is applied only when needed prior to red light therapy, you will not be on a dosing schedule.
What happens if I overdose (Metvixia)?
Seek emergency medical attention if you think you have used too much of this medicine.
Symptoms of a methyl aminolevulinate overdose are not known.
What should I avoid while taking methyl aminolevulinate (Metvixia)?
Tell your caregivers right away if any of this medication gets into your eyes, mouth, or nose.
Avoid touching the treated skin areas after methyl aminolevulinate cream has been applied to them. Special gloves must be worn by the healthcare provider while applying this medication, and you should not allow your own fingers to come into contact with the cream on your skin.
For at least 48 hours after your treatment, avoid exposing treated skin to sunlight, sunlamps, tanning beds, or other bright lights. Sunscreen is not effective enough to protect treated skin from harm caused by bring light during this time. Wear protective clothing whenever you are outdoors.
Even if you do not receive the light therapy portion of your treatment, you must still protect your skin from light for 48 hours after the cream was applied.
What other drugs will affect methyl aminolevulinate (Metvixia)?
Tell your doctor about all other medications you use, especially drugs that can make your skin more sensitive to sunlight, such as:
- amiodarone (Cordarone, Pacerone);
- diabetes medications you take by mouth;
- diltiazem (Tiazac, Cartia, Cardizem);
- furosemide (Lasix);
- porfimer (Photofrin);
- quinidine (Quinaglute, Quinidex, Quin-Release);
- tacrolimus (Prograf);
- verteporfin (Visudyne);
- an ACE inhibitor such as benazepril (Lotensin), captopril (Capoten), fosinopril (Monopril), enalapril (Vasotec), lisinopril (Prinivil, Zestril), moexipril (Univasc), perindopril (Aceon), quinapril (Accupril), ramipril (Altace), or trandolapril (Mavik);
- an antibiotic such as ciprofloxacin (Cipro), doxycycline (Adoxa, Doryx, Oracea, Vibramycin), minocycline (Dynacin, Minocin, Solodyn, Vectrin), levofloxacin (Levaquin), ofloxacin (Floxin), norfloxacin (Noroxin), tetracycline (Brodspec, Panmycin, Sumycin, Tetracap);
- a diuretic (water pill) such as hydrochlorothiazide (HCTZ), contained in Aldoril, Atacand, Capozide, HydroDiuril, Hyzaar, Lopressor, Lotensin, Moduretic, Monopril, Tekturna, Teveten, Vaseretic, Zestoretic, Ziac, and others;
- an NSAID (non-steroidal anti-inflammatory drug) such as ibuprofen (Motrin, Advil), naproxen (Aleve, Naprosyn), diclofenac (Cataflam, Voltaren), etodolac (Lodine), indomethacin (Indocin), ketoprofen (Orudis), and others; or
- a sulfa drug (such as Bactrim, Septra, SMX-TMP, and others).
This list is not complete and there may be other drugs that can interact with methyl aminolevulinate. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.
Where can I get more information?
Your doctor or pharmacist can provide more information about methyl aminolevulinate.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2013 Cerner Multum, Inc. Version: 1.03. Revision date: 12/15/2010.
Your use of the content provided in this service indicates that you have read,understood and agree to the End-User License Agreement,which can be accessed by clicking on this link.
Additional Metvixia Information
- Metvixia Drug Interactions Center: methyl aminolevulinate top
- Metvixia Side Effects Center
- Metvixia FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.